Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | 0.00% | 0.00% | +2.56% |
May. 13 | Compass Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 06 | Top Premarket Gainers | MT |
Business Summary
Number of employees: 32
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 16-12-31 | |
Thomas Schuetz
FOU | Founder | 63 | 13-12-31 |
Neil Lerner
DFI | Director of Finance/CFO | 56 | 19-12-31 |
Karin Herrera
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Minori Rosales
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-04-30 |
General Counsel | - | 21-07-31 | |
Ian Chia
PRN | Corporate Officer/Principal | - | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Lindahl
BRD | Director/Board Member | 70 | 23-04-20 |
Mary Gray
BRD | Director/Board Member | 71 | 22-04-24 |
Ellen Chiniara
BRD | Director/Board Member | 65 | 22-04-24 |
Carl Gordon
CHM | Chairman | 59 | 14-12-31 |
Phil Ferneau
BRD | Director/Board Member | 62 | 14-12-31 |
Thomas Schuetz
FOU | Founder | 63 | 13-12-31 |
James Boylan
BRD | Director/Board Member | 57 | 22-10-31 |
Chief Executive Officer | 53 | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 137,589,171 | 121,022,398 ( 87.96 %) | 0 | 87.96 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.56% | 220M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- CMPX Stock
- Company Compass Therapeutics, Inc.